U.S. flag

An official website of the United States government

NM_000492.4(CFTR):c.3208C>T (p.Arg1070Trp) AND Congenital bilateral absence of vas deferens

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Mar 30, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002221194.9

Allele description [Variation Report for NM_000492.4(CFTR):c.3208C>T (p.Arg1070Trp)]

NM_000492.4(CFTR):c.3208C>T (p.Arg1070Trp)

Genes:
CFTR:CF transmembrane conductance regulator [Gene - OMIM - HGNC]
LOC111674472:DNase I hypersensitive sites in introns 16 and 17a of CFTR [Gene]
Variant type:
single nucleotide variant
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000492.4(CFTR):c.3208C>T (p.Arg1070Trp)
HGVS:
  • NC_000007.14:g.117611649C>T
  • NG_016465.4:g.150866C>T
  • NG_056128.2:g.4703C>T
  • NM_000492.4:c.3208C>TMANE SELECT
  • NP_000483.3:p.Arg1070Trp
  • NP_000483.3:p.Arg1070Trp
  • LRG_663t1:c.3208C>T
  • LRG_663:g.150866C>T
  • LRG_663p1:p.Arg1070Trp
  • NC_000007.13:g.117251703C>T
  • NG_056128.1:g.4703C>T
  • NM_000492.3:c.3208C>T
  • P13569:p.Arg1070Trp
Protein change:
R1070W
Links:
PharmGKB: 1449191740PA165950341; UniProtKB: P13569#VAR_011564; dbSNP: rs202179988
NCBI 1000 Genomes Browser:
rs202179988
Molecular consequence:
  • NM_000492.4:c.3208C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Congenital bilateral absence of vas deferens
Identifiers:
MONDO: MONDO:0018801; MedGen: C1865433; OMIM: PS277180

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002498618Molecular Genetics, Royal Melbourne Hospital

See additional submitters

criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Mar 30, 2023)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Disease-associated mutations in the fourth cytoplasmic loop of cystic fibrosis transmembrane conductance regulator compromise biosynthetic processing and chloride channel activity.

Seibert FS, Linsdell P, Loo TW, Hanrahan JW, Clarke DM, Riordan JR.

J Biol Chem. 1996 Jun 21;271(25):15139-45.

PubMed [citation]
PMID:
8662892

Localization studies of rare missense mutations in cystic fibrosis transmembrane conductance regulator (CFTR) facilitate interpretation of genotype-phenotype relationships.

Krasnov KV, Tzetis M, Cheng J, Guggino WB, Cutting GR.

Hum Mutat. 2008 Nov;29(11):1364-72. doi: 10.1002/humu.20866.

PubMed [citation]
PMID:
18951463
PMCID:
PMC2785447
See all PubMed Citations (6)

Details of each submission

From Molecular Genetics, Royal Melbourne Hospital, SCV002498618.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This sequence change is predicted to replace arginine with tryptophan at codon 1070 of the CFTR protein, p.(Arg1070Trp). The arginine residue is evolutionarily conserved (100 vertebrates, UCSC), and is located in the fourth cytoplasmic loop of the cystic fibrosis transmembrane (CL4). There is a large physicochemical difference between arginine and tryptophan. The variant is present in a large population cohort at a frequency of 0.005%, which is consistent with recessive disease (rs202179988, 14/282,342 alleles, 0 homozygotes in gnomAD v2.1). It is classified as a CFTR variant of varying clinical consequences, and has been identified with a second pathogenic allele (mainly p.Phe508del) in non-classic pancreatic cystic fibrosis (CF), congenital bilateral absence of the vas deferens, and recurrent pancreatitis (for example PMID: 18951463, 31268981). The variant has also been identified as part of a complex allele that causes classic CF, when found in trans with a second pathogenic variant (PMID: 20880762). In vitro functional assays demonstrate that the variant causes mild defects on chloride transport and is inserted into the apical membrane at reduced levels (PMID: 8662892, 18951463, 23891399). Multiple lines of computational evidence predict a deleterious effect for the missense substitution (5/6 algorithms). Additionally, there is a different missense change (p.Arg1070Gln) at the same position determined to be pathogenic (ClinVar). Based on the classification scheme RMH Modified ACMG Guidelines v1.3.2, this variant is classified as PATHOGENIC. Following criteria are met: PM3_VeryStrong, PM5, PS3_Supporting, PM2_Supporting, PP3.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 24, 2024